Plain-English translation of NCT06061874 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new imaging scan called Ga68-FAPI PET/CT that may help doctors see cancer spread in the abdomen more clearly than older imaging methods. The scan uses a special radioactive tracer that highlights cancer cells and the tissue around them. Researchers want to see how accurate this new scan is before patients undergo surgery to remove the cancer.
Doctors currently use standard imaging scans to plan surgery for cancer that has spread to the abdominal lining, but these scans sometimes miss small areas of disease or are unclear. This new imaging method may be better at finding all the cancer, which could help surgeons plan better and give patients a better chance at successful treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive the new Ga68-FAPI PET/CT imaging scan before your planned surgery. If you are receiving chemotherapy first, you may have the scan both before and after that treatment. The scan itself takes about an hour and involves receiving a small injection of a radioactive tracer before lying still while the imaging machine scans your abdomen. Your scan results will then be compared with what doctors find during your surgery to see how accurate the new imaging method is.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Belgium
Sponsor
Jules Bordet Institute
Enrollment target
~80 participants
Started
May 2023
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Loubna Taraji Schiltz
Jules Bordet Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.